Search results for: 'purotoxin 1'
- L1048 DiscoveryProbe™ Inhibitor LibrarySummary: A unique collection of 2525 inhibitors for high throughput screening (HTS) and high content screening (HCS).
- L1045 DiscoveryProbe™ TGF-beta/Smad Compound LibrarySummary: A unique collection of 88 TGF-beta/Smad inhibitors for TGF-beta/Smad signaling pathway research.
- L1028 DiscoveryProbe™ Tyrosine Kinase Inhibitor LibrarySummary: A unique collection of 369 tyrosine kinase inhibitors for high throughput screening (HTS) and high content screening (HCS).
- L1042P DiscoveryProbe™ Immunology/Inflammation Compound Library PlusSummary: A unique collection of 806 small molecule compounds for immunology/inflammation research.
- L1037 DiscoveryProbe™ Cell Cycle LibrarySummary: A unique collection of 449 cell cycle-related compounds for cell cycle research.
- L1042 DiscoveryProbe™ Immunology/Inflammation Compound LibrarySummary: A unique collection of 295 small molecule compounds for immunology/inflammation research.
- A3007 ABT-263 (Navitoclax)15 CitationTarget: Bcl-2|Bcl-wSummary: Potent Bcl-2 family inhibitor, inhibits Bcl-2, Bcl-xL, and Bcl-w
- A8412 Dinaciclib (SCH727965)2 CitationTarget: Cyclin-Dependent KinasesSummary: Potent CDK inhibitor
- A8330 CX-4945 (Silmitasertib)9 CitationSummary: CK2 inhibitor
- B2303 Apatinib1 CitationSummary: VEGFR2 inhibitor, orally bioavailable, selective